Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KillerRed is a genetically encoded red fluorescent protein that functions as a potent photosensitizer, originally derived from the jellyfish Anemonia sulcata (Bulina et al., 2006, Nature Biotechnology). When exposed to green light, the chromophore of KillerRed undergoes a photochemical reaction that generates reactive oxygen species (ROS), specifically superoxide radicals, which cause localized oxidative damage to nearby cellular macromolecules such as proteins, lipids, and nucleic acids. This phenomenon is the basis for chromophore-assisted light inactivation (CALI), a technique used in cell biology to achieve high-precision, light-mediated knockdown of protein function in real-time. Because the term refers to a broad and variable set of molecules defined only by their proximity to the KillerRed protein during illumination, it does not represent a single therapeutic target or a specific biological receptor. Instead, it describes an experimental condition used to study protein function and cellular signaling pathways through induced oxidative stress. There are currently no therapeutic drugs that target this specific collection of molecules, as the interaction is mediated by light and the KillerRed protein itself in a research context. Consequently, this entity is primarily a tool for functional genomics and proteomics rather than a target for drug development.
Chromophore-assisted light inactivation (CALI) via green light-induced generation of superoxide radicals and other reactive oxygen species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules proximal to KillerRed.